UAB Biotechnologinės farmacijos centras "Biotechpharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 123,919,188 |
| 709,651 |
| 60,120,244 |
| 60,120,244 |
| 344,292 |
| 56.37 |
| 48.52 |
| 97,117,629 |
| 58,745,860 |
| 85,544,582 |
| 82,060,375 |
| 2023 |
|---|
| 93,045,600 |
| 575,670 |
| 50,779,570 |
| 50,779,570 |
| 314,172 |
| 63.31 |
| 54.57 |
| 94,214,496 |
| 61,164,150 |
| 56,086,298 |
| 110,169,310 |
| 2024 |
|---|
| 74,035,286 |
| 641,220 |
| 45,581,203 |
| 45,581,203 |
| 394,779 |
| 56.33 |
| 61.57 |
| 114,940,959 |
| 61,271,818 |
| 83,999,105 |
| 102,556,891 |
Register and
explore Okredo data| 2024 |
|---|
| 74,035,286 |
| 641,220 |
| 45,581,203 |
| 45,581,203 |
| 394,779 |
| 56.33 |
| 61.57 |
| 114,940,959 |
| 61,271,818 |
| 83,999,105 |
| 102,556,891 |
Register and
explore Okredo dataTurnover (€)
2024
Turnover (€)
74,035,286 €-20 % *
Sales per employee (€)
641,220 €11 % *
Profit before tax (€)
45,581,203 €-10 % *
Net Profit (€)
45,581,203 €-10 % *
Profit per employee (€)
394,779 €26 % *
Total profitability (%)
56.33 %-11.03 % *
Net profitability (%)
61.57 %12.83 % *
Equity (€)
114,940,959 €22 % *
Amounts Payable And Liabilities (€)
61,271,818 €0 % *
Non-current Assets (€)
83,999,105 €50 % *
CurrentAssets (€)
102,556,891 €-7 % *
